| Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients (NCT05590091) | Hebei Yanda Ludaopei Hospital | 2022-11-01 |
| LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (NCT05518357) | Hebei Yanda Ludaopei Hospital | 2022-06-24 |
| CD19/CD22-Dual-STAR-T for Patients With B Cell Acute Leukemia(B-ALL) (NCT04508842) | Hebei Yanda Ludaopei Hospital | 2020-10-10 |
| A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL (NCT04412174) | Hebei Yanda Ludaopei Hospital | 2020-06-01 |
| A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MM (NCT04412889) | Hebei Yanda Ludaopei Hospital | 2020-06-01 |
| CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients (NCT04260945) | Hebei Yanda Ludaopei Hospital | 2020-03-10 |
| CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients (NCT04260932) | Hebei Yanda Ludaopei Hospital | 2020-03-01 |
| EBV-TCR-T Cells for EB Virus Infection After HSCT (NCT04156217) | Hebei Yanda Ludaopei Hospital | 2020-02-10 |
| CMV-TCR-T Cells for CM Virus Infection After HSCT (NCT04153279) | Hebei Yanda Ludaopei Hospital | 2019-12-19 |
| A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL (NCT04129099) | Hebei Yanda Ludaopei Hospital | 2019-10-22 |
| CD19-Synthetic T Cell Antigen Receptor(STAR)-T in B-cell Malignancies Patients (NCT03953599) | Hebei Yanda Ludaopei Hospital | 2019-07-01 |
| A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL (NCT03825731) | Hebei Yanda Ludaopei Hospital | 2019-01-17 |
| A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL (NCT03825718) | Hebei Yanda Ludaopei Hospital | 2019-01-17 |
| A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma (NCT03751293) | Hebei Yanda Ludaopei Hospital | 2019-01-08 |